Improving Telehealth Delivery of HIV Prevention Medicine in the United States
Tests small changes to messages and websites for telehealth HIV prevention care.
Plain-language title generated from the registry record
Registry title: Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study
Key facts
- Where
- Atlanta, United StatesSee the site
Where in United States
- Emory University Rollins School of Public HealthAtlanta, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Emory University
- Trial code
- NCT07821671
- Record updated
- 16 September 2026
- Original description
This study uses a rapid randomized controlled trial (RCT) design to examine HIV pre-exposure prophylaxis (PrEP) delivered through telehealth. This study will develop a knowledge base of small, effective changes to digital messaging and website design to improve telemedicine PrEP (telePrEP) provision for MISTR users in the United States.Read full original descriptionShow less
Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study
This study uses a rapid randomized controlled trial (RCT) design to examine HIV pre-exposure prophylaxis (PrEP) delivered through telehealth. This study will develop a knowledge base of small, effective changes to digital messaging and website design to improve telemedicine PrEP (telePrEP) provision for MISTR users in the United States.
Inclusion: Adults aged >= 18 years; Individuals who use MISTR services; Reside in the United States.
Exclusion: Individuals who do not use MISTR services; Individuals who do not reside in the United States.